The start of a so-called rolling review formally begins an FDA evaluation of a closely watched drug that’s important to the biotech’s future, but faces questions about its sales potential.
A test to gauge if it's safe to prescribe a patient an addictive opioid may have been approved too soon by the U.S. Food and ...
Higher doses of Narcan — or naloxone — do not affect the possibility of survival after an overdose. Be cautious.
Some argue a need for more potent — and pricier — overdose reversal drugs; others frame that effort as drugmakers peddling ...
LITTLE ROCK (KATV) — A new additional drug in the fight against the opioid overdose crisis has slowly been making its way across the country and it is now available right here in Arkansas, a ...
The start of the opioid epidemic is ironically linked to a drug that was supposed to help people suffering from moderate to ...
Nutriband is targeting a 505(b)(2) NDA to the FDA for marketing approval of AVERSA™ Fentanyl in Q1 2025 ORLANDO, FL / ...
Physicians said the test is based “on old genetic studies that have largely been abandoned” and could exacerbate the opioid crisis.
A group of 31 experts in genetics, addiction, psychiatry, and medical-device regulation sent letters to the FDA and Centers for Medicare and Medicaid Services, The Washington Post reported. The ...
Researchers say a test meant to measure risk for opioid use disorder may cause harm. Their arguments are part of a larger ...
Purdue Pharma has asked the federal Food and Drug Administration (FDA) to approve a new, auto-injectable form of one of its drugs to treat opioid overdoses. The Stamford-based biopharmaceutical ...
Michigan must give its first responders additional tools to combat opioid overdoses amid the rise in fentanyl. That includes ...